FDA Panel Votes To Allow Moderna Boosters For Certain Populations

FDA’s vaccine advisory committee unanimously voted Thursday (Oct. 14) in favor of FDA authorizing Moderna’s COVID-19 vaccine booster for the 65-and-older population and those who are at high risk or face occupational hazards that increase their chances of catching COVID-19, but not without debate over concerns that there are not enough data to support the need for boosters. If FDA falls in line with the committee’s vote -- which it typically does -- Moderna’s booster would be authorized for use...